Bibliographic details
Loyd M, Rublee D, Jacobs P. An economic model of long-term use of celecoxib in patients with osteoarthritis. BMC Gastroenterology 2007; 7: 25
MeSH
Age Factors; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal /economics /therapeutic use; Celecoxib; Cost-Benefit Analysis; Diclofenac /economics /therapeutic use; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Long-Term Care; Male; Maximum Tolerated Dose; Middle Aged; Models, Economic; Naproxen /economics /therapeutic use; Osteoarthritis /diagnosis /drug therapy /economics; Probability; Pyrazoles /economics /therapeutic use; Quality-Adjusted Life Years; Risk Factors; Sensitivity and Specificity; Severity of Illness Index; Sulfonamides /economics /therapeutic use